NCT04592406View on ClinicalTrials.gov

Data on the Prevention of Complications of Prophylactic Intravenous Hydration in Patients With eGFR < 30

CompletedOBSERVATIONAL
Enrollment

443

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

January 6, 2023

Study Completion Date

January 6, 2023

Conditions
Acute Kidney Injury (Nontraumatic)Contrast-induced Nephropathy
Interventions
OTHER

CVP screening

An appropriate dual screening process including both renal and cardiac parameters to minimize the risks of post-contrast renal adverse outcomes and of prophylactic hydration in eGFR\<30mL/min/1.73m2 patients.

Trial Locations (1)

Unknown

Maastricht UMC, Maastricht

All Listed Sponsors
lead

Maastricht University Medical Center

OTHER

NCT04592406 - Data on the Prevention of Complications of Prophylactic Intravenous Hydration in Patients With eGFR < 30 | Biotech Hunter | Biotech Hunter